|
Q2 Resverlogix/Zenith Events
|
7
|
Resverlogix Corp.
|
Apr 12, 2016 12:17PM
|
|
ZEN003694 Trial is now recruiting patients
|
3
|
Zenith Epigenetics
|
Apr 13, 2016 01:14PM
|
|
ZEN003694 Trial Locations
|
4
|
Zenith Epigenetics
|
Apr 15, 2016 05:05PM
|
|
Re: Another study from JONZABOT on the other board
|
2
|
Resverlogix Corp.
|
Apr 17, 2016 01:54PM
|
|
Re: Q2 Zenith/Resverlogix Events
|
4
|
Zenith Epigenetics
|
Apr 17, 2016 02:11PM
|
|
Licensing The Transcend Platform – A New Era in Neuroscience
|
|
BIOASIS TECHNOLOGIES INC
|
Apr 18, 2016 10:37PM
|
|
Re: NYAS Symposium on Apr 28
|
3
|
Resverlogix Corp.
|
Apr 19, 2016 01:11PM
|
|
Genentech/Roche BET inhibitor toxicity paper
|
5
|
Resverlogix Corp.
|
Apr 19, 2016 02:46PM
|
|
Re: Genentech/Roche BET inhibitor toxicity paper
|
6
|
Resverlogix Corp.
|
Apr 20, 2016 11:12AM
|
|
Re: I'm Bullish Again on RVX and ZENITH
|
4
|
Zenith Epigenetics
|
Apr 21, 2016 03:47PM
|
|
Re: NYAS Symposium on Apr 28
|
4
|
Resverlogix Corp.
|
Apr 21, 2016 03:52PM
|
|
Re: NYAS Symposium on Apr 28
|
4
|
Resverlogix Corp.
|
Apr 21, 2016 04:03PM
|
|
Re: I'm Bullish Again on RVX and ZENITH
|
3
|
Zenith Epigenetics
|
Apr 21, 2016 04:03PM
|
|
Re: Licensing Deal - Very Little Detail - Astellas Research
|
1
|
BIOASIS TECHNOLOGIES INC
|
Apr 21, 2016 09:20PM
|
|
BiOasis Enters into a License Agreement with Astellas Research Institute
|
2
|
BIOASIS TECHNOLOGIES INC
|
Apr 21, 2016 09:23PM
|
|
Re: NYAS Symposium on Apr 28
|
4
|
Resverlogix Corp.
|
Apr 21, 2016 10:17PM
|
|
Re: BiOasis Enters into a License Agreement with Astellas Research Institute
|
1
|
BIOASIS TECHNOLOGIES INC
|
Apr 21, 2016 10:30PM
|
|
Re: NYAS Symposium on Apr 28
|
5
|
Resverlogix Corp.
|
Apr 22, 2016 11:12AM
|
|
Re: I'm Bullish Again on RVX and ZENITH
|
3
|
Zenith Epigenetics
|
Apr 22, 2016 11:13AM
|
|
Re: ... have you taken notice?...
|
6
|
Resverlogix Corp.
|
Apr 22, 2016 02:44PM
|
